Talk:Breast cancer–related regulator of tp53

Gene Wiki Low‑importance

	This article is within the scope of the Gene Wiki project, a taskforce of WikiProject Molecular Biology. To participate, visit the project page for more information.Gene WikiWikipedia:WikiProject Gene WikiTemplate:WikiProject Gene WikiGene Wiki articles
Low	This article has been rated as Low-importance on the importance scale.

Molecular Biology: MCB

	This article is within the scope of WikiProject Molecular Biology, a collaborative effort to improve the coverage of Molecular Biology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.Molecular BiologyWikipedia:WikiProject Molecular BiologyTemplate:WikiProject Molecular BiologyMolecular Biology articles
???	This article has not yet received a rating on the importance scale.
	This article is supported by the Molecular and Cell Biology task force (assessed as Low-importance).

On 24 July 2020, it was proposed that this article be moved from Breast cancer-related regulator of tp53 to Breast cancer–related regulator of tp53. The result of the discussion was moved.

Requested move 24 July 2020[edit]

The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.

The result of the move request was: moved per MOS:SUFFIXDASH, and consistency with other articles. —usernamekiran (talk) 09:43, 5 August 2020 (UTC)[reply]

– Per MOS:SUFFIXDASH and the recent RMs at Talk:Index of Ascension Island–related articles, Talk:Middle East respiratory syndrome–related coronavirus, and Talk:Severe acute respiratory syndrome–related coronavirus. —BarrelProof (talk) 01:37, 24 July 2020 (UTC)[reply]

The discussion above is closed. Please do not modify it. Subsequent comments should be made on the appropriate discussion page. No further edits should be made to this discussion.